Yang, L.; Gilbertsen, A.; Jacobson, B.; Kratzke, R.; Henke, C.A.
Serum Splicing Factor Proline- and Glutamine-Rich Is a Diagnostic Marker for Non-Small-Cell Lung Cancer and Other Solid Cancers. Int. J. Mol. Sci. 2024, 25, 8766.
https://doi.org/10.3390/ijms25168766
AMA Style
Yang L, Gilbertsen A, Jacobson B, Kratzke R, Henke CA.
Serum Splicing Factor Proline- and Glutamine-Rich Is a Diagnostic Marker for Non-Small-Cell Lung Cancer and Other Solid Cancers. International Journal of Molecular Sciences. 2024; 25(16):8766.
https://doi.org/10.3390/ijms25168766
Chicago/Turabian Style
Yang, Libang, Adam Gilbertsen, Blake Jacobson, Robert Kratzke, and Craig A. Henke.
2024. "Serum Splicing Factor Proline- and Glutamine-Rich Is a Diagnostic Marker for Non-Small-Cell Lung Cancer and Other Solid Cancers" International Journal of Molecular Sciences 25, no. 16: 8766.
https://doi.org/10.3390/ijms25168766
APA Style
Yang, L., Gilbertsen, A., Jacobson, B., Kratzke, R., & Henke, C. A.
(2024). Serum Splicing Factor Proline- and Glutamine-Rich Is a Diagnostic Marker for Non-Small-Cell Lung Cancer and Other Solid Cancers. International Journal of Molecular Sciences, 25(16), 8766.
https://doi.org/10.3390/ijms25168766